Cite
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.
MLA
Spellman, Daniel S., et al. “Development and Evaluation of a Multiplexed Mass Spectrometry Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF.” Proteomics. Clinical Applications, vol. 9, no. 7–8, Aug. 2015, pp. 715–31. EBSCOhost, https://doi.org/10.1002/prca.201400178.
APA
Spellman, D. S., Wildsmith, K. R., Honigberg, L. A., Tuefferd, M., Baker, D., Raghavan, N., Nairn, A. C., Croteau, P., Schirm, M., Allard, R., Lamontagne, J., Chelsky, D., Hoffmann, S., & Potter, W. Z. (2015). Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF. Proteomics. Clinical Applications, 9(7–8), 715–731. https://doi.org/10.1002/prca.201400178
Chicago
Spellman, Daniel S, Kristin R Wildsmith, Lee A Honigberg, Marianne Tuefferd, David Baker, Nandini Raghavan, Angus C Nairn, et al. 2015. “Development and Evaluation of a Multiplexed Mass Spectrometry Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF.” Proteomics. Clinical Applications 9 (7–8): 715–31. doi:10.1002/prca.201400178.